TUSTIN, Calif., Jan. 30, 2025 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ: CDMO) (“Avid” or the “Company”), a dedicated biologics…

TUSTIN, Calif.and LONDONand BOSTON,Nov. 06, 2024(GLOBE NEWSWIRE) –Avid Bioservices, Inc.(NASDAQ: CDMO) (“Avid” or the “Company”), a dedicated biologics contract development…

TUSTIN, Calif.,Sept. 12, 2024(GLOBE NEWSWIRE) –Avid Bioservices, Inc.(NASDAQ: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to…

TUSTIN, Calif.,May 23, 2024(GLOBE NEWSWIRE) –Avid Bioservices, Inc.(NASDAQ: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to…

TUSTIN, Calif.,Sept. 26, 2023(GLOBE NEWSWIRE) –Avid Bioservices, Inc.(NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve…

TUSTIN, Calif.,May 10, 2023(GLOBE NEWSWIRE) –Avid Bioservices, Inc.(NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve…

Company to Host Open House to Celebrate Official Launch of Newest CGMP Mammalian Cell Manufacturing Suites within Myford Facility First…

TUSTIN, Calif.,Nov. 02, 2022(GLOBE NEWSWIRE) –Avid Bioservices, Inc.(NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve…

TUSTIN, Calif.,Sept. 27, 2022(GLOBE NEWSWIRE) –Avid Bioservices, Inc.(NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve…